IDGLOBAL to begin working directly with its partner

10 Jan '08

3 min read

Also in January, IDGLOBAL will begin working directly with its partner, ATL Pharma Security Label Systems a division of Ad Tape & Label Co, by directly marketing its Nano-Molecular Markers to ATL's list of pharmaceutical clients which include some of the largest companies in that vertical.

IDGLOBAL secured an unprecedented ten year contract to supply its Nano-Molecular Marking anti-counterfeiting technology to ATL Pharma Security Label Systems as announced back on July 24, 2007 and December 4, 2007.

ATL is one of the world's leading secure label solutions providers, manufacturing more than half of all pharmaceutical clinical trial labels for most of the major pharmaceutical corporations.

In the past seven years ATL has produced more than 120 million pharmaceutical labels (including 19-page booklets) in over 80 languages, for over 1700 clinical trials.

In business since 1951, ATL is an FDA Registered Medical Device manufacturer that also specializes in “private brand” disposable medical device manufacturing.

Chief Technical Officer Hired (CTO):
IDGLOBAL continues to grow its base of qualified and technical staffing with the hiring of a Chief Technical Officer (CTO) to overlook and guide the Research and Development and technical infrastructure of the company. IDGLOBAL will provide specifics on this individual very shortly.

Research and Development:
IDGLOBAL has expanded its use of its Nano-Molecular Markers to include military and munitions applications. Prior tests successfully concluded that its Nano-Molecular Markers survived detonation of the munitions and sees multiple applications going forward.

IDGLOBAL sees this application as a potentially significant weapon in equipping authorities in combating terrorist and criminal activities.

IDGLOBAL Corp

More Textiles News - Canada...